Investors are always looking for stocks that are poised to beat at earnings season and Cue Biopharma, Inc. CUE may be one such company. The firm has earnings coming up pretty soon, and events are ...
Analyst Reni Benjamin of JMP Securities reiterated a Buy rating on Cue Biopharma (CUE – Research Report), with a price target of $15.00. Reni Benjamin has given his Buy rating due to a combination of ...
A downtrend has been apparent in Cue Biopharma, Inc. (CUE) lately. While the stock has lost 5.4% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback